Covered recipient · General Payments record
FURHAN YUNUS
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2019–2025
$54,791.73
- Reported across 327 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,564.53 | 65 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $198.59 | 9 |
| Incyte Corporation | $164.60 | 3 |
| Celgene Corporation | $128.32 | 5 |
| RECORDATI_RARE_DISEASES_INC. | $120.80 | 1 |
| Janssen Biotech, Inc. | $117.20 | 7 |
| Merck Sharp & Dohme Corporation | $112.74 | 6 |
| GlaxoSmithKline, LLC. | $85.31 | 4 |
| E.R. Squibb & Sons, L.L.C. | $73.34 | 4 |
| Daiichi Sankyo Inc. | $72.75 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $53.90 | 2 |
| BeOne Medicines USA, Inc. | $51.81 | 2 |
| PFIZER INC. | $51.73 | 3 |
| Deciphera Pharmaceuticals Inc. | $39.26 | 2 |
| TerSera Therapeutics LLC | $35.46 | 1 |
| Genmab U.S., Inc. | $35.40 | 2 |
| Acerta Pharma LLC | $33.69 | 2 |
| Kite Pharma, Inc. | $26.37 | 1 |
| Lilly USA, LLC | $23.10 | 1 |
| Coherus Biosciences Inc. | $22.16 | 1 |
| ABBVIE INC. | $22.05 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $21.53 | 1 |
| Gilead Sciences, Inc. | $20.55 | 1 |
| Astellas Pharma US Inc | $19.76 | 1 |
| Caris MPI, Inc. | $19.35 | 1 |
| Rigel Pharmaceuticals, Inc. | $14.76 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (65)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.